These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6293832)

  • 1. Uremic neuropathy: correlations between electroneurographic parameters and serum levels of parathyroid hormone and aluminum.
    Aiello I; Serra G; Gilli P; Rosati G; Manca M; De Bastiani P; Fagioli F
    Eur Neurol; 1982; 21(6):396-400. PubMed ID: 6293832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.
    Avram MM; Feinfeld DA; Huatuco AH
    N Engl J Med; 1978 May; 298(18):1000-3. PubMed ID: 205786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nervous system complications in uremia.
    Fraser CL; Arieff AI
    Ann Intern Med; 1988 Jul; 109(2):143-53. PubMed ID: 2837930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?
    Friga V; Linos A; Linos DA
    Nephron; 1997; 75(1):48-53. PubMed ID: 9031270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Utility of electrophysiologic study using the blink reflex and brainstem evoked potentials for the evaluation of the course of uremic polyneuropathy].
    Baldini S; Radicioni R; Melappioni M; Baldassari M; Panichi N; Pelliccioni G; Guidi M; Rosa L; Magnaterra R; Scarpino O
    Minerva Urol Nefrol; 1995 Mar; 47(1):13-7. PubMed ID: 7570255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uremic neuropathy--I. Is uremic neuropathy related to patient age, duration of nephropathy and dialysis treatment?].
    Jedras M; Zakrzewska-Pniewska B; Wardyn K; Switalski M
    Pol Arch Med Wewn; 1998 Jun; 99(6):452-61. PubMed ID: 10085699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremic neuropathy: clinical and neurophysiological investigation of dialysis patients using different chemical membranes.
    Violante F; Lorenzi S; Fusello M
    Eur Neurol; 1985; 24(6):398-404. PubMed ID: 4065159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parathormone and peripheral neuropathy in patients on chronic hemodialysis].
    Kostić SM; Djordjević V; Stefanović V
    Srp Arh Celok Lek; 1985; 113(5-6):467-72. PubMed ID: 3003934
    [No Abstract]   [Full Text] [Related]  

  • 11. Uremic vagal neuropathy: has parathyroid hormone a pathogenetic role?
    Vita G; Savica V; Calabrò R; Padovano I; Manna L; Toscano A; Rotondo S; Bellinghieri G
    Funct Neurol; 1986; 1(3):253-9. PubMed ID: 3609857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of aluminium on parathyroid hormone levels in haemodialysis patients.
    Cannata JB; Briggs JD; Junor BJ; Beastall G; Fell GS
    Proc Eur Dial Transplant Assoc; 1983; 19():244-7. PubMed ID: 6878239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uremic polyneuropathy: clinico-electroneurographic study of 36 cases].
    Werneck LC; Mulinari AS; Laffite A; Kesikowski LB
    Arq Neuropsiquiatr; 1979 Dec; 37(4):356-72. PubMed ID: 93959
    [No Abstract]   [Full Text] [Related]  

  • 14. Features of uremic neuropathy in long-term dialysis.
    Jurcić D; Bago J; Eljuga D; Milutinović S; Bobinac A; Bakula V; Bilić A
    Coll Antropol; 1998 Jun; 22(1):119-25. PubMed ID: 10097427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone as a uremic neurotoxin.
    N Engl J Med; 1978 Aug; 299(7):362-3. PubMed ID: 210381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes of PTH, 1,25(OH)2D3 and biochemistry in renal osteodystrophy].
    Jia JK; Lou DX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):33-6. PubMed ID: 8045186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone control survey to determine inter-method and inter-lab variations in Japan.
    Kakuta T; Kato H; Komaba H; Akizawa T;
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():50-5. PubMed ID: 21595853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from uremic neuropathy.
    Asbury AK
    N Engl J Med; 1971 May; 284(21):1211-2. PubMed ID: 4324616
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of high-tone external muscle stimulation on symptoms and electrophysiological parameters of uremic peripheral neuropathy.
    Strempska B; Bilinska M; Weyde W; Koszewicz M; Madziarska K; Golebiowski T; Klinger M
    Clin Nephrol; 2013 Jan; 79 Suppl 1():S24-7. PubMed ID: 23249529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients.
    Mallamaci F; Zoccali C; Ciccarelli M; Briggs JD
    Clin Nephrol; 1986 Apr; 25(4):175-80. PubMed ID: 3516480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.